The treatment of metastatic non-small cell lung cancer in the elderly: an evidence-based approach
An increasing proportion of patients with advanced NSCLC are over 70 years old, raising unique challenges for treatment decision-making. While these patients are underrepresented in clinical trials, there is an emerging body of evidence associated with this group. The lesson of comprehensive geriatr...
Main Authors: | David E Dawe, Peter Michael Ellis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00178/full |
Similar Items
-
Chemotherapy and Targeted Agents in the Treatment of Elderly Patients with Metastatic Colorectal Cancer
by: Albert Tuca, et al.
Published: (2020-12-01) -
Cisplatin-based Chemotherapy in Elderly Patients with Non-small Cell Lung Cancer
by: Jian Li, et al.
Published: (2010-03-01) -
Efficacy and Safety of Low-Dose Nab-Paclitaxel Plus Tislelizumab in Elderly Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
by: Wenyu Zhu, et al.
Published: (2022-03-01) -
Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer
by: Zaid Sirhan, et al.
Published: (2023-08-01) -
Clinical Observation of Metronomic Oral Vinorelbine Monotherapy as First-line Treatment on Elderly Patients with Advanced Non-small Cell Lung Cancer
by: LIN Jinlan, et al.
Published: (2018-11-01)